A new partnership had led to the development of the first-ever automated insulin delivery (AID) system that incorporates a 1-year glucose sensor. The twiist AID is approved for people aged 6 years or ...

Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated ...

MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic began the U.S. rollout on Tuesday of its latest ...

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

Automated insulin delivery (AID) systems are transforming how people with Type 1 diabetes manage their condition, offering tighter glucose control and more freedom in daily life. Yet, access to this ...

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for incorrect high glucose readings. After parts of her large intestine died and ...

In a development towards personalised healthcare, researchers at BITS Pilani Hyderabad campus have developed a miniaturised electrochemical sensor capable of simultaneously detecting insulin and ...

Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...